IQVIA艾昆纬：2025年药物警戒挑战的答案：人工智能驱动的不良事件检测报告（英文版）

As AI and Machine Learning (ML) technologies expand their reach across a wide range of industries, the Pharmacovigilance (PV) and device safety space is no exception. Due to the growing number of sources for Adverse Events (AE), pharma companies are navigating previously unprecedented volumes of data from which they must identify AEs and extract Individual Case Safety Reports (ICSRs) to protect patient safety and ensure regulatory compliance. As a result, many companies are turning to AI-powe